Clik here to view.
Race To Nowhere
Racial profiling – long in the realm of bad law enforcement – was criticized as bad medicine, too, in a recent paper by scientists from the Mount Sinai School of Medicine. The reason? As the authors...
View ArticleClik here to view.
The Good, the Bad and . . . the Huh? A 2011 Biotech Recap
The past year brought the biotech sector a mixed bag of news. Some of it was positive – for instance, the FDA picked up its drug approval pace in 2011 and, in some cases, even surprised the most...
View ArticleClik here to view.
He Said What?!?! Best Biotech Quotes of 2011
As BioWorld Insight readers know, our “Word on the Street” column provides a sample of the most entertaining and thought-provoking quotes our staff stumbles upon each week. Some are gathered during...
View ArticleClik here to view.
Patient Experience Still Undervalued in Regulating Drugs
As I write this, I’m sitting in the University of British Columbia/Vancouver General Hospital (UBC/VGH) Eye Care Centre, where my husband, Chuck, is completing post-tests at the conclusion of a...
View Article
